Logo image of YCBD

CBDMD INC (YCBD) Stock Price, Quote, News and Overview

NYSEARCA:YCBD - NYSE Arca - US12482W3097 - Common Stock - Currency: USD

0.9263  -0.02 (-2.49%)

YCBD Quote, Performance and Key Statistics

CBDMD INC

NYSEARCA:YCBD (5/13/2025, 9:39:54 AM)

0.9263

-0.02 (-2.49%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High6.54
52 Week Low0.76
Market Cap5.80M
Shares6.26M
Float5.40M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-14 2025-05-14
IPO11-17 2017-11-17


YCBD short term performance overview.The bars show the price performance of YCBD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

YCBD long term performance overview.The bars show the price performance of YCBD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of YCBD is 0.9263 USD. In the past month the price decreased by -45.75%. In the past year, price decreased by -83.4%.

CBDMD INC / YCBD Daily stock chart

YCBD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 53.89 702.99B
JNJ JOHNSON & JOHNSON 14.92 360.89B
NVO NOVO-NORDISK A/S-SPONS ADR 18.96 288.65B
NVS NOVARTIS AG-SPONSORED ADR 12.94 212.40B
AZN ASTRAZENECA PLC-SPONS ADR 18.13 209.12B
MRK MERCK & CO. INC. 9.95 195.10B
PFE PFIZER INC 7.02 127.88B
SNY SANOFI-ADR 13.34 122.76B
BMY BRISTOL-MYERS SQUIBB CO 6.36 95.00B
GSK GSK PLC-SPON ADR 6.7 73.34B
ZTS ZOETIS INC 26.7 71.70B
HLN HALEON PLC-ADR 21.9 47.40B

About YCBD

Company Profile

YCBD logo image cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Company Info

CBDMD INC

8845 Red Oak Blvd

Charlotte NORTH CAROLINA 28217 US

CEO: Martin A. Sumichrast

Employees: 42

YCBD Company Website

YCBD Investor Relations

Phone: 17044453060

CBDMD INC / YCBD FAQ

What is the stock price of CBDMD INC today?

The current stock price of YCBD is 0.9263 USD. The price decreased by -2.49% in the last trading session.


What is the ticker symbol for CBDMD INC stock?

The exchange symbol of CBDMD INC is YCBD and it is listed on the NYSE Arca exchange.


On which exchange is YCBD stock listed?

YCBD stock is listed on the NYSE Arca exchange.


What is CBDMD INC worth?

CBDMD INC (YCBD) has a market capitalization of 5.80M USD. This makes YCBD a Nano Cap stock.


How many employees does CBDMD INC have?

CBDMD INC (YCBD) currently has 42 employees.


What are the support and resistance levels for CBDMD INC (YCBD) stock?

CBDMD INC (YCBD) has a resistance level at 1.57. Check the full technical report for a detailed analysis of YCBD support and resistance levels.


Is CBDMD INC (YCBD) expected to grow?

The Revenue of CBDMD INC (YCBD) is expected to grow by 9.38% in the next year. Check the estimates tab for more information on the YCBD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CBDMD INC (YCBD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CBDMD INC (YCBD) stock pay dividends?

YCBD does not pay a dividend.


When does CBDMD INC (YCBD) report earnings?

CBDMD INC (YCBD) will report earnings on 2025-05-14.


What is the Price/Earnings (PE) ratio of CBDMD INC (YCBD)?

CBDMD INC (YCBD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.24).


YCBD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

YCBD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to YCBD. YCBD may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

YCBD Financial Highlights

Over the last trailing twelve months YCBD reported a non-GAAP Earnings per Share(EPS) of -10.24. The EPS increased by 90.68% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -57.98%
ROE -375.65%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%67.16%
Sales Q2Q%-4.87%
EPS 1Y (TTM)90.68%
Revenue 1Y (TTM)-18.02%

YCBD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to YCBD. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 71.11% and a revenue growth 9.38% for YCBD


Ownership
Inst Owners2.97%
Ins Owners7.54%
Short Float %N/A
Short Ratio1.05
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y71.11%
Revenue Next Year9.38%